Water-Jel Technologies International

Currently, there is no recognised single dermatological prophylactic “standard of care” for patients undergoing high-dose radiotherapy treatment. Water-Jel Technologies have developed a two-part treatment R1 R2 containing lactokine, which is clinically proven to prevent or delay the onset and reduce severity of radiotherapy dermatitis.

Water-Jel International
3-4 The Mead Business Centre
Mead Lane
Hertford, England SG13 7BJ  United Kingdom
01992 583222
https://us.radiotherapytreatment.com/